U.S. market Closed. Opens in 17 hours 1 minute

GNLX | Genelux Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue170.00K11.07MN/AN/AN/A
Cost of Revenue1.02M968.00K895.00K658.00K477.00K
Gross Profit-848.00K10.10M-895.00K-658.00K-477.00K
Operating Expenses23.32M14.08M14.61M12.42M10.39M
Selling, General & Admin10.55M5.00M8.29M6.20M2.86M
Research & Development12.77M9.08M6.32M6.23M7.53M
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-24.16M-3.01M-14.61M-12.42M-10.87M
Other Expenses / Income-4.13M-1.09M-1.76M-1.22M-761.00K
Before Tax Income-28.30M-4.11M-16.38M-13.64M-11.63M
Income Tax Expenses850.11K1.10M1.42M1.22MN/A
Net Income-28.30M-5.21M-17.80M-14.86M-11.63M
Interest Expenses822.00K1.41M1.42M1.22M761.00K
Basic Shares Outstanding24.43M24.55M23.62M23.62M23.62M
Diluted Shares Outstanding24.43M24.55M23.62M23.62M23.62M
EBITDA-23.15M-2.04M-14.12M-11.76M-10.39M
EBITDA Margin-13,615.88%-18.48%0.00%0.00%0.00%
EBIT-26.62M-2.70M-14.96M-12.42M-10.87M
EBIT Margin-15,661.70%-24.39%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙